This study investigates the heart functioning of patients receiving chemotherapy for sarcoma, lymphoma, or breast cancer. The focus is on understanding how the treatment affects the heart and predicting the risk of developing heart failure. Chemotherapy is a type of cancer treatment that uses drugs to destroy cancer cells, but it can also affect the heart.
Participants will undergo procedures to monitor their heart function while receiving chemotherapy. This may include imaging tests and other assessments to evaluate how the heart is working during the treatment.
- Who can participate: Eligible participants are adults diagnosed with sarcoma, lymphoma, or breast cancer who are undergoing treatment with doxorubicin investigational chemotherapy.
- Study details: Participants will be monitored for changes in heart function during their investigational chemotherapy treatment. This monitoring may involve imaging tests to assess the heart's response to the treatment.
